Key facts
- Ascertain’s last known valuation is $35.0M (Apr 2025).
- It has raised $17.4M across 1 recorded rounds; the latest was Early Stage VC ($7.4M) in Mar 2024.
- Notable investors include Deerfield Management, Aegis Ventures, Northwell Health.
- Ascertain has filed 1 Form D with the SEC, most recently Mar 2024 ($7.4M sold to 2 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Ascertain
Funding rounds
1 roundsAbout Ascertain
Operator of an artificial intelligence-powered healthcare platform intended to streamline administrative workflows and reduce operational burden in clinical settings. The company offers agentic AI software and tech-enabled services that automate tasks like prior authorization, eligibility checks, and patient scheduling, enabling health systems, payers, and provider groups to lower costs, improve efficiency, and focus more on patient care.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2022
- Employees
- 38
- Website
- ascertain.com/
- Ownership
- Privately Held (backing)
Ascertain doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ascertain shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ascertain in its N-PORT filings yet. We sweep new filings monthly.